Similar Articles
1181 LncRNAs expression signatures of hepatocellular carcinoma revealed by microarray
1182 Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: A meta-analysis
1183 Identification of biomarkers for hepatocellular carcinoma by semiquantitative immunocytochemistry
1184 Laparoscopic liver resections for hepatocellular carcinoma: Current role and limitations
1185 MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma
1186 Hepatocellular carcinoma review: Current treatment, and evidence-based medicine
1187 Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma
1188 Staging systems of hepatocellular carcinoma: A review of literature
1189 Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age
1190 Anatomic resection of liver segments 6-8 for hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA